• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性乳腺癌中血管基因表达的改变。

Alterations in vascular gene expression in invasive breast carcinoma.

作者信息

Parker Belinda S, Argani Pedram, Cook Brian P, Liangfeng Han, Chartrand Scott D, Zhang Mindy, Saha Saurabh, Bardelli Alberto, Jiang Yide, St Martin Thia B, Nacht Mariana, Teicher Beverly A, Klinger Katherine W, Sukumar Saraswati, Madden Stephen L

机构信息

Breast Cancer Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Cancer Res. 2004 Nov 1;64(21):7857-66. doi: 10.1158/0008-5472.CAN-04-1976.

DOI:10.1158/0008-5472.CAN-04-1976
PMID:15520192
Abstract

The molecular signature that defines tumor microvasculature will likely provide clues as to how vascular-dependent tumor proliferation is regulated. Using purified endothelial cells, we generated a database of gene expression changes accompanying vascular proliferation in invasive breast cancer. In contrast to normal mammary vasculature, invasive breast cancer vasculature expresses extracellular matrix and surface proteins characteristic of proliferating and migrating endothelial cells. We define and validate the up-regulated expression of VE-cadherin and osteonectin in breast tumor vasculature. In contrast to other tumor types, invasive breast cancer vasculature induced a high expression level of specific transcription factors, including SNAIL1 and HEYL, that may drive gene expression changes necessary for breast tumor neovascularization. We demonstrate the expression of HEYL in tumor endothelial cells and additionally establish the ability of HEYL to both induce proliferation and attenuate programmed cell death of primary endothelial cells in vitro. We also establish that an additional intracellular protein and previously defined metastasis-associated gene, PRL3, appears to be expressed predominately in the vasculature of invasive breast cancers and is able to enhance the migration of endothelial cells in vitro. Together, our results provide unique insights into vascular regulation in breast tumors and suggest specific roles for genes in driving tumor angiogenesis.

摘要

定义肿瘤微血管系统的分子特征可能会为血管依赖性肿瘤增殖的调控方式提供线索。我们利用纯化的内皮细胞,建立了一个伴随浸润性乳腺癌血管增殖的基因表达变化数据库。与正常乳腺血管系统相比,浸润性乳腺癌血管系统表达增殖和迁移的内皮细胞所特有的细胞外基质和表面蛋白。我们定义并验证了乳腺肿瘤血管中VE-钙黏蛋白和骨连接蛋白的上调表达。与其他肿瘤类型不同,浸润性乳腺癌血管系统诱导了包括SNAIL1和HEYL在内的特定转录因子的高表达水平,这些转录因子可能驱动乳腺肿瘤新生血管形成所需的基因表达变化。我们证明了HEYL在肿瘤内皮细胞中的表达,并进一步证实了HEYL在体外既能诱导原代内皮细胞增殖又能减弱其程序性细胞死亡的能力。我们还证实,另一种细胞内蛋白以及先前定义的转移相关基因PRL3似乎主要在浸润性乳腺癌的血管系统中表达,并且能够在体外增强内皮细胞的迁移。总之,我们的结果为乳腺肿瘤中的血管调控提供了独特的见解,并表明了基因在驱动肿瘤血管生成中的特定作用。

相似文献

1
Alterations in vascular gene expression in invasive breast carcinoma.浸润性乳腺癌中血管基因表达的改变。
Cancer Res. 2004 Nov 1;64(21):7857-66. doi: 10.1158/0008-5472.CAN-04-1976.
2
c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer.c-Jun激活与浸润性乳腺癌的增殖和血管生成相关。
Hum Pathol. 2006 Jun;37(6):668-74. doi: 10.1016/j.humpath.2006.01.022.
3
Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.通过逆转录病毒介导的TIMP-2基因转移抑制在裸鼠乳腺脂肪垫中建立的MDA-MB 435人乳腺癌的远处肺转移。
J Gene Med. 2005 Feb;7(2):145-57. doi: 10.1002/jgm.645.
4
Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.浸润性导管癌细胞中Id-1的过表达与雌激素受体阴性/淋巴结阳性乳腺癌的瘤内微血管密度显著相关。
Cancer Lett. 2006 Dec 8;244(2):203-10. doi: 10.1016/j.canlet.2005.12.016. Epub 2006 Feb 8.
5
Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.在一种可靠的人类乳腺癌小鼠模型中,转移肿瘤抗原家族蛋白在乳腺癌进展和转移过程中的作用
Clin Cancer Res. 2006 Mar 1;12(5):1479-86. doi: 10.1158/1078-0432.CCR-05-1519.
6
A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.环氧化酶-2在调控人乳腺癌细胞形成血管通道中的新作用。
Breast Cancer Res. 2006;8(6):R69. doi: 10.1186/bcr1626.
7
[Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance].[血管生成相关因子在浸润性乳腺癌中的表达及其临床意义]
Nan Fang Yi Ke Da Xue Xue Bao. 2006 Jun;26(6):860-3.
8
Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression.乳腺癌中血管生成相关蛋白膜联蛋白II:在浸润性乳腺癌中的选择性表达及其对肿瘤侵袭和进展的作用
Exp Mol Pathol. 2006 Oct;81(2):146-56. doi: 10.1016/j.yexmp.2006.03.003. Epub 2006 Apr 27.
9
Gene alterations in tumor-associated endothelial cells from endometrial cancer.子宫内膜癌肿瘤相关内皮细胞中的基因改变。
Int J Mol Med. 2008 Nov;22(5):619-32.
10
The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is associated with P-selectin expression in breast cancers.血管生成因子胸苷磷酸化酶上调人血管内皮细胞中的细胞粘附分子P-选择素,并与乳腺癌中的P-选择素表达相关。
J Pathol. 2007 Jul;212(3):335-44. doi: 10.1002/path.2174.

引用本文的文献

1
PRL3-zumab as an anti-angiogenic therapy in neovascular eye diseases.PRL3 单抗作为新生血管性眼病的抗血管生成疗法
Nat Commun. 2025 May 23;16(1):4791. doi: 10.1038/s41467-025-59929-2.
2
Normalization of Snai1-mediated vessel dysfunction increases drug response in cancer.Snai1 介导的血管功能正常化可增加癌症的药物反应。
Oncogene. 2024 Aug;43(35):2661-2676. doi: 10.1038/s41388-024-03113-1. Epub 2024 Aug 2.
3
Extracellular vesicles derived from SARS-CoV-2 M-protein-induced triple negative breast cancer cells promoted the ability of tissue stem cells supporting cancer progression.
源自严重急性呼吸综合征冠状病毒2(SARS-CoV-2)M蛋白诱导的三阴性乳腺癌细胞的细胞外囊泡促进了组织干细胞支持癌症进展的能力。
Front Oncol. 2024 Mar 7;14:1346312. doi: 10.3389/fonc.2024.1346312. eCollection 2024.
4
The Crosstalk between Mesenchymal Stromal/Stem Cells and Hepatocytes in Homeostasis and under Stress.间质基质/干细胞与肝细胞在稳态和应激中的串扰。
Int J Mol Sci. 2023 Oct 16;24(20):15212. doi: 10.3390/ijms242015212.
5
PRL3 as a therapeutic target for novel cancer immunotherapy in multiple cancer types.PRL3 作为多种癌症新型癌症免疫疗法的治疗靶点。
Theranostics. 2023 Mar 21;13(6):1876-1891. doi: 10.7150/thno.79265. eCollection 2023.
6
Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer.Notch 信号通路:乳腺癌的综合预后和基因表达谱分析。
BMC Cancer. 2022 Dec 7;22(1):1282. doi: 10.1186/s12885-022-10383-z.
7
Suppression of CCL2 angiocrine function by adrenomedullin promotes tumor growth.肾上腺髓质素抑制 CCL2 的血管生成功能可促进肿瘤生长。
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20211628. Epub 2022 Nov 14.
8
Biological aspects in controlling angiogenesis: current progress.控制血管生成的生物学方面:当前进展。
Cell Mol Life Sci. 2022 Jun 7;79(7):349. doi: 10.1007/s00018-022-04348-5.
9
Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.原花青素 G 通过糖原合酶激酶 3β 介导的 SNAIL 和组蛋白去乙酰化酶 6 调控的波形蛋白降解抑制三阴性乳腺癌细胞的上皮间质转化。
Int J Mol Sci. 2022 Jan 31;23(3):1672. doi: 10.3390/ijms23031672.
10
Regulation of Partial and Reversible Endothelial-to-Mesenchymal Transition in Angiogenesis.血管生成中部分和可逆的内皮-间充质转化的调控
Front Cell Dev Biol. 2021 Oct 7;9:702021. doi: 10.3389/fcell.2021.702021. eCollection 2021.